HIV treatment bulletin

RSS Atom • ISSN 1472-4683 • Subscribe • About

12th Conference on Retrovirus and Opportunistic Infections, 22-25 February, Boston, 2005

• Paediatric reports from 12th Conference on Retrovirus and Opportunistic Infections (CROI) Conference reports - Conference index - CROI 12 (Retrovirus) 2005 - 15 May 2005

• Once-daily lopinavir/ritonavir for children may offer advantages Conference reports - Paediatric care - CROI 12 (Retrovirus) 2005 - 15 May 2005

• Lopinavir/ritonavir for young infants Conference reports - Paediatric care - CROI 12 (Retrovirus) 2005 - 15 May 2005

• Paediatric dose finding atazanavir and atazanavir/ritonavir Conference reports - Paediatric care - CROI 12 (Retrovirus) 2005 - 15 May 2005

• Switching d4T to tenofovir and protease inhibitor to efavirenz Conference reports - Paediatric care - CROI 12 (Retrovirus) 2005 - 15 May 2005

• 12th Conference on Retrovirus and Opportunistic Infections, 22-25 February, Boston, 2005 Conference reports - Conference index - CROI 12 (Retrovirus) 2005 - 18 April 2005

• Developments in nevirapine use in MTCT reduction Conference reports - PMTCT and maternal health - CROI 12 (Retrovirus) 2005 - 18 April 2005

• Mashi study – late breakers on breastfeeding Conference reports - PMTCT and maternal health - CROI 12 (Retrovirus) 2005 - 18 April 2005

• Maternal health and infant mortality Conference reports - PMTCT and maternal health - CROI 12 (Retrovirus) 2005 - 18 April 2005

• Paediatric care in lower income settings Conference reports - Paediatric care - CROI 12 (Retrovirus) 2005 - 18 April 2005

• Tenofovir not linked to bone toxicity in children followed for one year Conference reports - Paediatric care - CROI 12 (Retrovirus) 2005 - 18 April 2005

• Gut memory CD4 T cells implicated in a central role for HIV disease pathology: dramatic impact prior to seroconversion Basic science and immunology - Conference reports - CROI 12 (Retrovirus) 2005 - 18 April 2005

• Case of multi-drug resistant (MDR) rapid progressor Basic science and immunology - Conference reports - CROI 12 (Retrovirus) 2005 - 18 April 2005

• Case report of antibody reversion and negative viral load four-years after treatment discontinuation Basic science and immunology - Conference reports - CROI 12 (Retrovirus) 2005 - 18 April 2005

• 24-week efficacy of TMC114 in PI-experienced patients Antiretrovirals - Conference reports - CROI 12 (Retrovirus) 2005 - 18 April 2005

• Maturation inhibitor shows anti-HIV activity in single dose pilot study Antiretrovirals - Conference reports - CROI 12 (Retrovirus) 2005 - 18 April 2005

• New antiretrovirals at 12th CROI Antiretrovirals - Conference reports - CROI 12 (Retrovirus) 2005 - 18 April 2005

• Absolute risk is modest, but cumulative cardiovascular risk of HAART over five years is similar to 'ever smoked': new data on gender and age Conference reports - Side effects - CROI 12 (Retrovirus) 2005 - 18 April 2005

• Omega-3 supplement effective to reduce triglycerides Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 12 (Retrovirus) 2005 - 18 April 2005

• Entecavir is effective against 3TC-resistant hepatitis B Conference reports - Hepatitis coinfection - CROI 12 (Retrovirus) 2005 - 18 April 2005

• Switch to tenofovir from AZT or d4T improves fat loss and improves lipid parameters compared to abacavir Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 12 (Retrovirus) 2005 - 18 April 2005

• Continued use of a thymidine analogue may limit benefit from rosiglitazone when used to treat lipoatrophy Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 12 (Retrovirus) 2005 - 18 April 2005

• Tenofovir is non-inferior to adefovir for the treatment of hepatitis B in HBV-HIV co-infected patients Conference reports - Hepatitis coinfection - CROI 12 (Retrovirus) 2005 - 18 April 2005